Overview
Isolated congenital nasal pyriform aperture stenosis (CNPAS) is a rare congenital malformation characterized by abnormal narrowing of the bony nasal inlet — the pyriform aperture — which is the narrowest fixed point of the nasal airway. Because neonates are obligate nasal breathers, this narrowing can cause significant respiratory distress, particularly during feeding, and may present with cyclical cyanosis that improves with crying (when the infant breathes through the mouth). The condition is termed 'isolated' when it occurs without other associated anomalies, distinguishing it from cases where pyriform aperture stenosis is found alongside other midline defects such as a solitary median maxillary central incisor, holoprosencephaly, or pituitary abnormalities. Clinical features typically manifest in the neonatal period and include nasal obstruction, noisy breathing (stertor), feeding difficulties, and episodes of apnea or desaturation. Diagnosis is confirmed by computed tomography (CT) scan of the nasal passages, which demonstrates a pyriform aperture width of less than approximately 11 mm in a term neonate. The narrowing results from overgrowth of the nasal process of the maxillary bone. Treatment depends on the severity of symptoms. Mild cases may be managed conservatively with humidified air, nasal saline drops, nasal decongestants, and the use of an oral airway (such as a McGovern nipple) until the nasal passages grow sufficiently to allow adequate airflow. In more severe cases where the infant cannot maintain adequate oxygenation or feed safely, surgical intervention is required. The standard surgical approach involves sublabial access to drill or remove the excess bone of the pyriform aperture to widen the nasal inlet. Outcomes following surgical correction are generally excellent, with most infants achieving normal nasal breathing and feeding.
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Isolated congenital nasal pyriform aperture stenosis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Isolated congenital nasal pyriform aperture stenosis at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Isolated congenital nasal pyriform aperture stenosis.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Isolated congenital nasal pyriform aperture stenosis.
Community
No community posts yet. Be the first to share your experience with Isolated congenital nasal pyriform aperture stenosis.
Start the conversation →Latest news about Isolated congenital nasal pyriform aperture stenosis
No recent news articles for Isolated congenital nasal pyriform aperture stenosis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Isolated congenital nasal pyriform aperture stenosis
What is Isolated congenital nasal pyriform aperture stenosis?
Isolated congenital nasal pyriform aperture stenosis (CNPAS) is a rare congenital malformation characterized by abnormal narrowing of the bony nasal inlet — the pyriform aperture — which is the narrowest fixed point of the nasal airway. Because neonates are obligate nasal breathers, this narrowing can cause significant respiratory distress, particularly during feeding, and may present with cyclical cyanosis that improves with crying (when the infant breathes through the mouth). The condition is termed 'isolated' when it occurs without other associated anomalies, distinguishing it from cases wh
How is Isolated congenital nasal pyriform aperture stenosis inherited?
Isolated congenital nasal pyriform aperture stenosis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Isolated congenital nasal pyriform aperture stenosis typically begin?
Typical onset of Isolated congenital nasal pyriform aperture stenosis is neonatal. Age of onset can vary across affected individuals.